Holen Sie sich die Stockscreener-App
8.68
0.46%
0.04
Schlusskurs vom Vortag:
$8.64
Offen:
$8.65
24-Stunden-Volumen:
174.20K
Relative Volume:
0.72
Marktkapitalisierung:
$2.60B
Einnahmen:
$391.87M
Nettoeinkommen (Verlust:
$-441.45M
KGV:
-4.6919
EPS:
-1.85
Netto-Cashflow:
$-301.21M
1W Leistung:
+3.21%
1M Leistung:
-7.17%
6M Leistung:
-34.69%
1J Leistung:
-27.67%
1-Tages-Spanne:
$8.51
$8.71
1-Wochen-Bereich:
$8.37
$8.91
52-Wochen-Spanne:
$7.35
$13.70
Alvotech Stock (ALVO) Company Profile
Vergleichen Sie ALVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
8.68 | 2.60B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | UBS | Buy |
| 2024-01-29 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Herabstufung | Citigroup | Buy → Sell |
| 2022-07-26 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Alvotech Aktie (ALVO) Neueste Nachrichten
What drives Alvotech Equity Warrant stock priceFree Stock Movement Tracking - Autocar Professional
Alvotech Equity Warrant Stock Analysis and ForecastPhenomenal returns - jammulinksnews.com
What analysts say about Alvotech stockUnmatched profit growth - jammulinksnews.com
Is Alvotech Equity Warrant a good long term investmentAccelerated financial growth - Autocar Professional
Is Alvotech a good long term investmentAccelerated wealth building - jammulinksnews.com
What drives Alvotech stock priceHigh-return market picks - jammulinksnews.com
UBS Expects Alvotech To Bounce Back After Second-Quarter Dip - Finimize
UBS Says Alvotech Set for H2 Growth on Pipeline Launches, Private Label Deal - MarketScreener
What analysts say about Alvotech Equity Warrant stockBreakthrough profits - jammulinksnews.com
UBS Group Issues Pessimistic Forecast for Alvotech (NASDAQ:ALVO) Stock Price - MarketBeat
Alvotech names veteran Linda Jónsdóttir finance chief - MSN
Alvotech (ALVO) Announces Acquisition of Ivers-Lee Group - MSN
Alvotech (NASDAQ:ALVO) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Alvotech Stock Analysis and ForecastRecord-breaking gains - Jammu Links News
Alvotech price target lowered to $14 from $16 at UBS - TipRanks
UBS Adjusts Price Target on Alvotech to $14 From $16, Maintains Buy Rating - MarketScreener
Bio-Thera Matches Alvotech With US Golimumab Filing Acceptance - insights.citeline.com
Alvotech (ALVO) Down 6.6% in 4 Weeks, Analysts Expect Rebound - AInvest
Down 6.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Alvotech (ALVO) - Yahoo Finance
Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma - MSN
Alvotech (NASDAQ:ALVO) Shares Down 2.3%Here's What Happened - MarketBeat
Alvotech expands biosimilars capabilities with Ivers-Lee acquisition - MSN
Alvotech: A Fast Expanding Biosimilar Concern (NASDAQ:ALVO) - Seeking Alpha
Alvotech taps Linda Jónsdóttir as CFO - MSN
Alvotech Boosts Packaging Abilities With Ivers-Lee Acquisition - insights.citeline.com
Alvotech Names Chief Financial Officer - Contract Pharma
Finanzdaten der Alvotech-Aktie (ALVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):